NGM stock forecast
Our latest prediction for NGM Biopharmaceuticals, Inc.'s stock price was made on the Feb. 6, 2020 when the stock price was at 15.84$.
In the short term (2weeks), NGM's stock price should outperform the market by 1.01%. During that period the price should oscillate between -8.30% and +9.74%.
In the medium term (3months), NGM's stock price should underperform the market by -6.60%. During that period the price should oscillate between -29.08% and +25.19%.
Get email alertsAbout NGM Biopharmaceuticals, Inc.
NGM Biopharmaceuticals, Inc. engages in the discovery and development of therapeutics for major diseases with an initial focus on cardio-metabolic and liver diseases. Its portfolio if composed of product candidates which focuses on non-alcoholic steatohepatitis, type 2 diabetes, obesity, oncology and age-related macular degeneration. The company was founded by Jin-Long Chen in 2008 and is headquartered in South San Francisco, CA.
At the moment the company generates 120M USD in revenues.
On its last earning announcement, the company reported a loss of -0.19$ per share.
The book value per share is 2.88$
Three months stock forecastFeb. 6, 2020
Financials
| Revenue USD | Gross Margin | Operating Income | Operating Margin | Net Income | Earnings Per Share | Dividends | Payout Ratio | Shares | Book Value Per Share | Operating Cash Flow | Cap Spending | Free Cash Flow |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 120M | - | -19M | -15.90% | -13M | -0.19 | - | - | 66M | 2.88 | -20M | -3M | -22M |